EUVIMEDEUVIMED entdecken
Fallbericht

Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome

Athiphat Banjongjit, Wonngarm Kittanamongkolchai, Talerngsak Kanjanabuch

Nephron · 2023

DOI: 10.1159/000531879 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephron, 2023. Verfasst von Athiphat Banjongjit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Department of Medicine, Vichaiyut Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome, Thrombotic Microangiopathies, Eosinophilia, Acute Kidney Injury. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atypical hemolytic uremic syndrome (aHUS) is a condition characterized by acute kidney injury (AKI), thrombocytopenia, and microangiopathic hemolytic anemia secondary to complement pathway dysregulation. Several triggers have been identified as causing aHUS in genetically susceptible patients; however, hypereosinophilia syndrome (HES)-triggered aHUS has not been reported. In this article, we present a case of aHUS presented with generalized urticarial rashes and angioedema. The initial investigations revealed hypereosinophilia (maximal absolute eosinophil count of 6,840 cells/µL) with normal bone-marrow analyses; hence, idiopathic HES was diagnosed. During hospitalization, the patient developed convulsion, stuporous, and full-blown thrombotic microangiopathy (TMA), with AKI requiring temporary hemodialysis. A kidney biopsy confirmed the existence of renal TMA. Next-generation sequencing of the coding regions of aHUS-related genes was performed, revealing an underlying complement factor I (CFI) deficiency, a heterozygous variant p.P64L of CFI gene. The patient was successfully treated with high-dose steroids and extended duration of plasmapheresis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atypical Hemolytic Uremic SyndromeThrombotic MicroangiopathiesEosinophiliaAcute Kidney InjuryComplement C3Complement Factor IHumansHereditary Complement Deficiency Diseases

Stichwörter der Autor:innen

Atypical hemolytic uremic syndromeComplement factor IHypereosinophilic syndromep.P64L mutation

Substanzen

Complement Factor IComplement C3

Autor:innen und Institutionen

  • Nephrology Unit, Department of Medicine, Vichaiyut Hospital, Bangkok, Thailand.
  • Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Mahachakri Sirindhorn Clinical Research Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Renal Immunology and Renal Transplant Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Zitieren

APA

Banjongjit, A., Kittanamongkolchai, W., & Kanjanabuch, T. (2023). Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome. Nephron. https://doi.org/10.1159/000531879

Vancouver

Banjongjit A, Kittanamongkolchai W, Kanjanabuch T. Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome. Nephron. 2023. doi:10.1159/000531879

BibTeX
@article{Banjongjit2023,
  author = {Banjongjit, Athiphat and Kittanamongkolchai, Wonngarm and Kanjanabuch, Talerngsak},
  title = {Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome},
  journal = {Nephron},
  year = {2023},
  doi = {10.1159/000531879}
}
Kostenlos starten →